News
Lumonus inks joint venture with NY cancer centre to scale AI oncology
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
Company
Anchorage Capital Group
Funding history
Investors
Every investor coverage indicates participated in a round Anchorage Capital Group raised.
What Anchorage Capital Group bought
Companies Anchorage Capital Group acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
| Name | Role | Sources |
|---|---|---|
| Merrick Howes | Boss (former) | Brandon Capital portfolio (Wed 1 Apr 2026), Brandon Capital portfolio (Tue 23 Mar 2021) |
Coverage
Stories naming Anchorage Capital Group. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Key hire
GBST appoints Kirsty Worgan as global Chief Commercial Officer
Fintech firm GBST has hired Kirsty Worgan as its global Chief Commercial Officer, returning her to the company where she previously led business development, with responsibility for commercial growth and mergers and acquisitions.
6 deals
Brandon Capital news
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Cut Through Venture·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·Forbes Australia·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com·Forbes Australia